SUSCEPTIBILITY OF BORDETELLA PERTUSSIS STRAINS TO ANTIBACTERIAL PREPARATIONS
https://doi.org/10.22627/2072-8107-2013-12-2-46-50
Abstract
178 strains of B. pertussis isolated from infected individuals in various regions of Russia from 1948 to 2012 have been studied for their susceptibility to six antibacterial preparations. It has been shown, that B. pertussis strains isolated from 1948 to 1989 were predominantly sensitive to erythromycin. In the following years a gradual decrease in susceptibility of circulating strains of B. pertussis to this antibiotic was registered with the emergence of strains with intermediate susceptibility in 22% of cases from 1990 to 2005 (MIC 0,060 mcg/mL), up to 59,3% in the last six years (MIC 0,125 mcg/mL). As for azithromycin, high susceptibility of strains of B. pertussis to this preparation was shown throughout the entire duration of the survey. However, the rate of incidence of intermediate strains reached 14% among those strains isolated from 1990 to 2005, and is now at 32%. Thus, after several decades of active use of antibiotics pertussis underwent a series of transformations resulting in a decrease in susceptibility of B. pertussis strains to erythromycin and azithromycin.
About the Authors
O. Yu. Borisova
Moscow Research Institute of Epidemiology and Microbiology named after G.N. Gabrichevsky, Moscow
Russian Federation
Russian Federation
A. V. Aleshkin
Moscow Research Institute of Epidemiology and Microbiology named after G.N. Gabrichevsky, Moscow
Russian Federation
Russian Federation
G. A. Ivashinnikova
Moscow Research Institute of Epidemiology and Microbiology named after G.N. Gabrichevsky, Moscow
Russian Federation
Russian Federation
E. E. Donskikh
Russian National Research Medical University named after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
E. A. Postnikova
Russian National Research Medical University named after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
V. A. Alyeshkin
Moscow Research Institute of Epidemiology and Microbiology named after G.N. Gabrichevsky, Moscow
Russian Federation
Russian Federation
References
1. . Ультраструктура свежевыделенных штаммов B. pertussis / Бакулина Н.А., Ефимова О.Г., ВысотскийВ.В., Шакирова Р.Г. // Журн. микробиологии. — 1984; 11: 24—26.
2. Характеристика свойств штаммов возбудителя коклюша, выделенных от больных в 1980—90-е годы в Москве: Сб. научн. трудов «Актуальные проблемы инфекционной патологии» / Ефимова О.Г., Сигаева Л.А., Савинкова В.С., Новикова А.А. — 1999; 1 : 119.
3. Петрова М.С., Сигаева Л А., Антонова Н.А. Клиника коклюша на этапах массовой вакцинопрофилактики: Сб. научн. трудов «Вакцинопрофилактике — 200 лет». — 1997; 1 : 54—56.
4. Особенности эпидемиологии и клиники коклюша в период эпидемического неблагополучия: Сб. научн. трудов «Проблемы инфекционных болезней»/ Петрова М.С., Сигаева Л.А., Попова О.П., Маркелов В.П., Звонарева С.В. — 2000; 1 : 80—86.
5. Антибиотикотерапия при коклюше у детей / Петрова М.С., Шакирова Р.Г., Антонова Н.А., Феоктистова Г.Н. // Антибиотики и химиотерапия. — 1992; 11 : 40—43.
6. Ценева Г.Я., Курова Н.Н. Микробиологическая характеристика возбудителя коклюша и лабораторная диагностика коклюша // Журн. Клин. микробиол. антимикроб. химиотер. — 2003; 4 (5): 329—341.
7. Курова Н.Н. Молекулярно-биологическая характеристика B.pertussis, циркулирующих в период подъема заболеваемости и совершенствование лабораторной диагностики коклюша: Автореф. дисс. ... к.м.н.. — 2003.
8. Bannatyne R., Cheung R. Antimicrobial susceptibility of B.pertussis strains isolated from 1960 to 1981// Antimicrob. Agents Chemother. — 1982; 21: 666—667.
9. Bannatyne R., Cheung R. Antibiotic resistance of degraded of B.pertussis strains // Antimicrob. Agents Chemother. — 1984; 25: 537—538.
10. Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis / Lewis K. et al // Pediatr. Infect. Dis. J. — 1995; 14 : 388—391.
11. Korgenski E.K., Daly J. . Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from pediatric population in the intermountain west region of the United States // J. Clin. Microbiol. — 1997; 35 : 2989—2991.
12. Barnes M.G., Weiss A.A. Growth phase influence complement resistance of B. pertussis // J. Infect. Immunity. — 2002; 70 (1): 403—406.
13. Lee B. Progressive respiratory distress in an infant treated for presumed pertussis // Pediatr. Infect. Dis. J. — 2000; 19 (475): 492— 493.
14. Hill B.C., Baker C.N., Tenover F.C. A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents // J. Clin. Microbiol. —2000; 38: 1151—1155.
15. Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance / Wilson K.E., Cassiday P.K., Popovic T., Sanden G.N. // J. Clin. Microbiol. — 2002; 40: 2942—2944.
16. Identification of a Mutation Associated with Erythromycin Resistance in Bordetella pertussis: Implications for Surveillance of Antimicrobial Resistance / Bartkus J.M. et al. // J. Clin. Microbiol. — 2003; 41 (3): 1167—1172.
17. Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method / Fry N.K., Duncan J., Vaghji L., George R.C., Harrison T.G. // Eur J. Clin. Microbiol. Infect. Dis. — 2010; 29 (9): 1183—1185.
18. Sintchenko V., Brown M., Gilbert L. Is B.pertussis susceptibility to erythromycin changing? MIC trends among Australian isolates 1971 — 2006 // J. Antimicrobial chemotherapy. — 2007; 60 (5): 1178—1179.
19. Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patient / Yao S.M. et al. // J. Med. Microbiol. — 2008; 57 (Pt. 12): 1577—80.
20. Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program / Gordon K.A., Fusco J., Biedenbach D.J., Pfaller M.A., Jones R.N. // Antimicrob Agents Chemother. — 2001. — 45 : 3599—3600.
21. Azithromycin is as effective as and better tolerated than erythromycin estolatefor the pertussis treatment / Langley J.M., Halperin S.A., Broucher F.D., Smith B. // Pediatrics. — 2004. — 114 (1): 96— 101
Review
For citations:
Borisova O.Yu., Aleshkin A.V., Ivashinnikova G.A., Donskikh E.E., Postnikova E.A., Alyeshkin V.A. SUSCEPTIBILITY OF BORDETELLA PERTUSSIS STRAINS TO ANTIBACTERIAL PREPARATIONS. CHILDREN INFECTIONS. 2013;12(2):46-50. (In Russ.) https://doi.org/10.22627/2072-8107-2013-12-2-46-50
Views:
1072
Email this article 